As of Jul 31
| -0.04 / -3.77%|
The 2 analysts offering 12-month price forecasts for Alexza Pharmaceuticals Inc have a median target of 2.25, with a high estimate of 3.00 and a low estimate of 1.50. The median estimate represents a +120.59% increase from the last price of 1.02.
The current consensus among 2 polled investment analysts is to Buy stock in Alexza Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.